Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-05 Sale |
2022-07-07 4:30 pm |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
12,861 | $3.705 | $47,650 | 530,589 (Direct) |
View |
| 2022-06-29 Sale |
2022-07-01 6:55 pm |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
50,139 | $3.6515 | $183,081 | 543,450 (Direct) |
View |
| 2021-06-29 Sale |
2021-07-01 6:32 pm |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
79,000 | $22.63 | $1,787,936 | 593,589 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-06 Option Award |
2022-04-08 4:26 pm |
N/A 2032-04-06 |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
40,325 | $0 | 40,325 (Direct) |
View |
| 2022-02-23 Option Award |
2022-02-25 4:20 pm |
N/A 2032-02-23 |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
80,650 | $0 | 80,650 (Direct) |
View |
| 2021-01-19 Option Award |
2021-01-20 8:21 pm |
N/A 2031-01-19 |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-09-28 Conversion |
2020-09-30 4:39 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
7,373 | $0 | 672,589 (Direct) |
View |
| 2020-09-23 Option Award |
2020-09-25 5:14 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
668,745 | $0 | 668,745 (Direct) |
View |
Ownership |
2020-09-23 8:30 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D |
0 | $0 | 3,844 (Direct) |
View |